Socioeconomic status (SES) remains associated with survival among cancer patients in Ontario, despite a universal healthcare approach, according to a study published online Aug. 2 in Cancer.
The cost patterns of prostate cancer treatment can vary widely based on initial treatment choice, and treatments that may be less expensive in the short-term may have higher long-term costs, according to a study published online Aug. 23 in Cancer.
Areva Med has formed an advisory committee comprised of five high-level scientists who will provide the firm with strategic advice and scientific guidance in the field of radio-immunotherapy using its lead-212 isotope.
The nuclear medicine community has been pressuring the U.S. government to develop improved domestic capability for producing these materials to reduce this dependence, said Robert Atcher, PhD, MBA, immediate past president of SNM and director of National Isotope Development Center at Los Alamos National Laboratory in White Rock, N.M., at an opening session of the 240th conference of the American Chemical Society, held this week in Boston.
Cancer and benign disease equipment manufacturer BSD Medical has been granted FDA clearance to market its soft tissue ablation system, the MicroThermX Microwave Ablation System, in the U.S.
Advanced Accelerator Applications has signed an agreement to build, install and operate a pharmaceutical laboratory for radiopharmaceuticals production at the Institut Curie’s René Huguenin cancer hospital in Paris.
MRI software company Acuitas Medical has garnered a £700,000 ($899,700 U.S.) co-investment from Finance Wales and Altima Global Special Opportunities Master Fund towards the development of its MR-based Fine Texture Analysis technology, and has named Sir Michael Brady as non-executive director of the board.
PHILADELPHIA--A new mathematical model to better pinpoint tumor location and thereby reduce radiation exposure uses data on how tumor motion has changed during a course of radiation treatment, along with real-time tumor images to calculate the confidence physicists can have about an instantaneous tumor position estimate. The research was presented July 21 at the annual meeting of the American Association of Physicists in Medicine (AAPM).
Written by Chris Kaiser
PHILADELPHIA—Six years ago, Jim Donnelly was told the cancer on his tongue and larynx needed to be surgically removed. Not accepting that opinion, Donnelly, a professor of business at the University of Kentucky, Lexington, decided to go to the Mayo Clinic in Rochester, Minn. As was evident by the standing ovation following his address at the annual meeting of the American Association of Physicists in Medicine (AAPM), Donnelly has not lost his ability to speak, nor his sense of humor.
SNM has recognized the contributions to the field of nuclear medicine and molecular imaging during its 57th annual meeting in Salt Lake City.
James Cook University Hospital in Middlesbrough, England has begun treating cancer patients via the TomoTherapy HiArt treatment system from radiation therapy provider TomoTherapy.
New health insurance plans or insurance policies beginning on or after Sept. 23 will be required to cover, without cost sharing, several recommended preventive healthcare services--including breast cancer screening--under the Patient Protection and Affordable Care Act.
By molecular imaging of genetically engineered T-cells with PET reporter genes as they seek out and attack the cancer cells, scientists can examine the processes of the immune system as it fights malignancies, which could then result in better monitoring response to therapy in melanoma patients, according to a study published July 12 in the early online edition of Proceedings of the National Academy of Sciences.
Written by Manjula Puthenedam
Cardiac imaging procedures represent an important source of ionizing radiation in the U.S., and the distribution of cumulative effective doses can lead to sizable radiation exposure for many individuals, according to a study published online July 7 in the Journal of the American College of Cardiology. Better strategies to minimize the radiation exposure from cardiac imaging procedures should be encouraged, said the study's lead author Jersey Chen, MD, in an interview.
Skandion Clinic, the clinical center for proton therapy in Sweden, has selected IBA (Ion Beam Applications) for the installation of a particle therapy facility, which will be managed by a consortium of seven Swedish counties, representing eight university hospitals.
Memorial Sloan-Kettering Cancer Center in New York City has opened a new $100 million, 40,000-square-foot Center for Image-Guided Intervention for cancer treatments, a new endoscopy suite and expanded its Surgical Day Hospital last month.
Proton Therapy and pharmaceutical investment company CareCapital have partnered to create a new company, Proton Therapy Global Management.
Shorter length of leukocyte telomeres–chromosome markers of biological aging–are associated with an increased risk of cancer and death from cancer, according to a study in the July 7 issue of Journal of the American Medical Association.
Hoag Breast Care Center of Hoag Memorial Hospital Presbyterian in Newport Beach, Calif., has selected Brachytherapy provider Xoft’s Axxent Electronic Brachytherapy system to support its new Intraoperative Radiation Therapy program for treatment of early stage breast cancer, endometrial cancer and skin cancer.
An optical imaging technique, Cerenkov luminescence imaging, shows excellent promise as a potential new method for rapid, high-throughput screening of radiopharmaceuticals, said a study published in the July issue of the Journal of Nuclear Medicine.
|